Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
GEGenetic Technologies Limited logo

Genetic Technologies Limited (GENE)

NASDAQ Capital Market · Currency in USD
$0.77 ▲ +0.00 (+0.00%)
At close: Nov 14, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.77
Open
--
Day's Range
$0.77 – $0.77
52 Week Range
$0.67 – $3.59
Volume
0
Avg. Volume
371
Market Cap
$111.24M
Beta (5Y Monthly)
0.48
PE Ratio (TTM)
--
EPS (TTM)
-$2.61
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Genetic Technologies Limited

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
55
CEO
Kevin Camilleri

Genetic Technologies Limited (GENE) is a molecular diagnostics company specializing in providing predictive testing and assessment tools. These solutions empower healthcare professionals to better manage women's health concerns in both Australia and the United States. Its flagship product, BREVAGenplus, is a clinically validated risk assessment test specifically designed for non-hereditary breast cancer.

Earnings

DateEst.Actual
Aug 29, 2024–-$0.03
Mar 19, 2024–-$1.09
Aug 29, 2023–-$0.63
Feb 23, 2023–-$0.78
Aug 30, 2022–-$0.73
Feb 23, 2022–-$0.92

Analyst view

Rating: Sell
Buy 0% · Hold 0% · Sell 100%

Get free alerts on GENE and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.